Effectiveness and safety of primary prophylaxis with G-CSF for lung cancer: a systematic review and meta-analysis to develop clinical practice guidelines for the use of G-CSF 2022

CONCLUSION: Limited data are available on G-CSF prophylaxis in lung cancer. Primary prophylaxis with G-CSF may be weakly recommended in Japanese patients with NSCLC undergoing docetaxel and ramucirumab combination therapy.PMID:38353907 | DOI:10.1007/s10147-024-02469-4

Source: Clinical Breast Cancer - February 14, 2024 Category: Cancer & Oncology Authors: Eiki Ichihara Nobuaki Ochi Go Makimoto Kenichiro Kudo Daijiro Harada Yukinori Ozaki Hiroshi Nishio Kenji Tsuchihashi Yuji Miura Makoto Endo Shingo Yano Dai Maruyama Tetsuhiro Yoshinami Nobuyuki Susumu Munetaka Takekuma Takashi Motohashi Mamoru Ito Eishi B Source Type: research